The largest database of trusted experimental protocols

L 368 899 hydrochloride

Manufactured by Bio-Techne
Sourced in United States

L-368,899 hydrochloride is a laboratory reagent supplied by Bio-Techne. It is a chemical compound used in research applications.

Automatically generated - may contain errors

6 protocols using l 368 899 hydrochloride

1

Pharmacology Experiments with OXT Antagonist and Agonist

Check if the same lab product or an alternative is used in the 5 most similar protocols
For pharmacology experiments, the OXT antagonist L-368,899 hydrochloride (Tocris Biosciences, 2641, 5 μM) and agonist WAY 267464 dihydrochloride (Tocris Biosciences, 3933, 5 μM) were added to each dish from the beginning of the isolation period (2 hrs prior to adding fluorescently labeled paramecia).
+ Open protocol
+ Expand
2

Leptin and Oxytocin Receptor Antagonist Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant mouse leptin (#498-OB, R&D Systems, Minneapolis, MN, USA) was dissolved in sterile saline at a concentration of 1.0 mg/ml and administered intraperitoneally (i.p.) at a dose of 1.0 mg/kg or 5.0 mg/kg body weight. For behavioral tests, leptin was administrated at a dose of 1.0 mg/kg, which has been used in our previous studies as an effective dose to produce behavioral effects including social interaction [25 (link), 26 (link), 28 (link), 29 (link), 52 , 53 ]. A high dose of leptin (5.0 mg/kg) was chosen to determine its effects on gene expression, as it has been reported to effectively induce downstream signaling, i.e., p-STAT3 and p-AKT [54 (link), 55 (link)]. A non-peptide selective oxytocin receptor antagonist (OTR-A), L-368,899 hydrochloride (#2641, Tocris Biosciences, Minneapolis, MN, USA) [56 (link), 57 ], was dissolved in sterile saline at a concentration of 2.0 mg/ml and administered by i.p. injections at a dose of 5.0 mg/kg body weight [58 (link)].
+ Open protocol
+ Expand
3

Early-life Pharmacological Modulation of the Serotonergic and Oxytocinergic Systems

Check if the same lab product or an alternative is used in the 5 most similar protocols
(R)-(+)-8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide (8OH-DPAT; Sigma, USA), a specific 5-HT1A receptor full agonist, L-368,899 hydrochloride (Tocris, UK), an OXT receptor antagonist, or OXT (Sigma, USA) was dissolved in saline and subcutaneously injected to pups (8OH-DPAT, 0.5 mg/kg; L-368,899, 3 mg/kg; OXT 83 I.U. [0.2–0.26 mg]/kg) every day from PD7 to PD21.
The treatment doses of 8OH-DPAT35 (link), L-368,89936 (link),37 (link) and OXT30 (link) were determined based on previous reports. The treatment duration of each drug was determined based on our previous reports5 (link). After weaning at PD21, the mice were divided into groups of two to five mice per cage. Saline was used as a control.
+ Open protocol
+ Expand
4

Oxytocin and Ethanol-Sucrose Behavior

Check if the same lab product or an alternative is used in the 5 most similar protocols
Synthetic human oxytocin (CellSciences, Canton, MA) and the oxytocin receptor antagonist, L-368,899 hydrochloride (Tocris Bioscience, Minneapolis, MN) were dissolved in 0.9% saline, which served as the vehicle. Injections were administered intraperitoneally at a volume of 0.01 ml/g body weight in all experiments. Ethanol (95%) was obtained from AAPER (Shelbyville, KY) and diluted with tap water to the appropriate concentration. Sucrose was also diluted to the appropriate concentration with tap water (5% w/v). The ethanol and sucrose solutions were prepared daily and presented at room temperature.
+ Open protocol
+ Expand
5

Oxytocin and Receptor Antagonist Injection

Check if the same lab product or an alternative is used in the 5 most similar protocols
OXT (Sigma-Aldrich, St Louis, MO, USA) and L-368,899 hydrochloride (Tocris Bioscience, Abingdon, UK), an OXT receptor antagonist, were dissolved in saline and subcutaneously injected into the mice. L-368,899 (10 mg/kg) was injected into pregnant WT female mice at GD19. The average length of time between injection and delivery was 6.9 h ± 26 min (n = 31). In the prenatal treatments, OXT (83 IU [0.2–0.26 mg]/kg) was injected into pregnant WT female mice 5 min before C/S (preOXT-C/S). In postnatal treatments, OXT (31.3 mIU/pup) was injected 30 min after delivery into naturally delivered or C/S-delivered pups as well as pups born to L-368,899-treated or OXT-KO dams (ND-OXT, C/S-OXT, LND-OXT, or IVF-OKO-OXT, respectively). The treatment doses of L-368,899 and OXT were determined based on previous reports27 (link). Saline vehicle was injected into all mice 30 min after delivery for the non-treated animals (ND, C/S, LND, IVF-WT, or IVF-OKO).
+ Open protocol
+ Expand
6

Oxytocin and Orexin Modulation of Drug Seeking

Check if the same lab product or an alternative is used in the 5 most similar protocols
Synthetic human oxytocin (Cell Sciences, CRO300GB) was dissolved in sterile water and administered at doses of 1 or 3 mg/kg (1 ml/kg, i.p.) 30 min prior to testing. This pretreatment interval and dose range were based on prior literature showing an effective reduction in drug seeking with minimal side effects [17 (link), 56 (link), 57 (link)]. The oxytocin receptor antagonist L-368,899 hydrochloride (Tocris, 2641) was dissolved in sterile water and administered at a dose of 5 mg/kg (1 ml/kg, i.p.) 30 min prior to testing, which has been shown to effectively block the effects of oxytocin in rats [58 (link)]. The dual orexin receptor antagonist DORA-12 (Merck) was dissolved in 5% DMSO + 40% captisol in sterile water and administered at doses of 10 mg/kg (1 ml/kg, i.p.) or 30 mg/kg (3 ml/kg, i.p.) based on effective doses of other DORAs reported in the literature [47 (link)–50 (link)]. Heroin (diamorphine hydrochloride) was dissolved in 0.9% saline (0.04 mg/50 μl infusion per reward). Dustless precision grain-based food pellets (45 mg each, Bio-Serv, F0165) were delivered in 3-pellet quantities per reward.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!